| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP53 USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 5.25e-20 | 114 | 160 | 19 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP53 USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.78e-19 | 124 | 160 | 19 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP53 USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.95e-18 | 137 | 160 | 19 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP53 USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.21e-15 | 192 | 160 | 19 | GO:0008234 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ATF7 ZBTB38 ZSCAN12 HDAC5 ZNF154 ZNF157 TRPS1 ZNF189 ZNF521 ZNF343 REST ZNF112 PRDM4 BATF2 ZNF623 CASZ1 ZBTB24 ZFX ZNF711 RLF ZNF600 ZNF713 ZNF28 ZNF33A ZNF556 ZNF451 ZBTB40 ZNF432 ZNF814 PLAG1 PLAGL1 PLAGL2 FOXO4 ZFHX3 ZNF81 ZNF606 PRDM16 ZNF292 | 2.27e-11 | 1412 | 160 | 38 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ATF7 ZBTB38 ZSCAN12 HDAC5 ZNF154 ZNF157 TRPS1 ZNF189 ZNF521 ZNF343 REST ZNF112 APP PRDM4 BATF2 ZNF623 CASZ1 ZBTB24 ZFX ZNF711 ZNF600 ZNF713 ZNF28 ZNF33A ZNF556 ZNF432 ZNF814 PLAG1 PLAGL1 FOXO4 ZFHX3 ZNF81 ZNF606 PRDM16 KDM6A | 3.52e-09 | 1459 | 160 | 35 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ATF7 ZBTB38 ZSCAN12 HDAC5 ZNF154 ZNF157 ZNF189 ZNF521 REST ZNF112 APP PRDM4 BATF2 ZNF623 ZBTB24 ZFX ZNF711 ZNF600 ZNF713 ZNF28 ZNF33A ZNF432 ZNF814 PLAG1 PLAGL1 FOXO4 ZFHX3 ZNF81 ZNF606 PRDM16 KDM6A | 1.38e-08 | 1244 | 160 | 31 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ATF7 ZBTB38 ZSCAN12 HDAC5 ZNF154 ZNF157 ZNF189 ZNF521 REST ZNF112 APP PRDM4 BATF2 ZNF623 ZBTB24 ZFX ZNF711 ZNF600 ZNF713 ZNF28 ZNF33A ZNF432 ZNF814 PLAG1 PLAGL1 FOXO4 ZFHX3 ZNF81 ZNF606 PRDM16 KDM6A | 2.26e-08 | 1271 | 160 | 31 | GO:0000987 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 USP53 USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.30e-06 | 654 | 160 | 19 | GO:0008233 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ZNF521 ZNF112 PRDM4 CASZ1 ZFX RLF ZNF600 ZNF33A ZNF814 PLAG1 PLAGL1 PLAGL2 FOXO4 ZNF606 PRDM16 ZNF292 | 1.16e-05 | 560 | 160 | 16 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ZNF521 ZNF112 PRDM4 CASZ1 ZFX RLF ZNF600 ZNF33A ZNF814 PLAG1 PLAGL1 PLAGL2 FOXO4 ZNF606 PRDM16 ZNF292 | 1.32e-05 | 566 | 160 | 16 | GO:0001216 |
| GeneOntologyMolecularFunction | nicotinic acid receptor activity | 6.38e-05 | 2 | 160 | 2 | GO:0070553 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 1.36e-04 | 13 | 160 | 3 | GO:0140410 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 6.28e-04 | 5 | 160 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 9.37e-04 | 6 | 160 | 2 | GO:0008510 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.13e-03 | 320 | 160 | 9 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.29e-03 | 326 | 160 | 9 | GO:0001217 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 2.11e-03 | 32 | 160 | 3 | GO:0015106 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP53 USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.24e-19 | 125 | 157 | 19 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP53 USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.98e-18 | 144 | 157 | 19 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L7 USP53 USP17L21 TRIML1 USP17L4 TRAF5 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 PTPN22 USP17L19 USP17L18 USP17L17 TRIM9 ZNF451 ZFP91 USP17L6P USP17L3 TNKS2 USP17L22 USP17L15 USP17L8 | 4.54e-08 | 1009 | 157 | 26 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L7 USP53 USP17L21 TRIML1 USP17L4 TRAF5 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 PTPN22 USP17L19 USP17L18 USP17L17 TRIM9 ZNF451 ZFP91 USP17L6P USP17L3 TNKS2 USP17L22 USP17L15 USP17L8 | 1.55e-07 | 1074 | 157 | 26 | GO:0043687 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ATF7 ZBTB38 ERCC6 HDAC5 ZNF521 REST ZNF112 APP PRDM4 CASZ1 ZFX ZNF711 RLF ZNF600 ZNF33A ZNF814 PLAG1 PLAGL1 PLAGL2 FOXO4 ZFHX3 ZNF606 PRDM16 KDM6A ZNF292 | 5.06e-05 | 1390 | 157 | 25 | GO:0045944 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 SYNE1 USP17L5 CLSTN2 USP17L19 TRAPPC2B RTN1 TMCC3 USP17L18 DST STX18 USP17L17 SYNE2 USP17L6P USP17L3 HRC USP17L22 USP17L15 USP17L8 TRAPPC2 | 5.57e-06 | 1327 | 156 | 26 | GO:0042175 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 CLSTN2 USP17L19 RTN1 TMCC3 USP17L18 DST STX18 USP17L17 SYNE2 USP17L6P USP17L3 HRC USP17L22 USP17L15 USP17L8 | 9.17e-05 | 1293 | 156 | 23 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 CLSTN2 USP17L19 RTN1 TMCC3 USP17L18 DST STX18 USP17L17 SYNE2 USP17L6P USP17L3 HRC USP17L22 USP17L15 USP17L8 | 9.82e-05 | 1299 | 156 | 23 | GO:0098827 |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 1.10e-04 | 13 | 156 | 3 | GO:1990907 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 2.21e-04 | 40 | 156 | 4 | GO:0005640 | |
| HumanPheno | Postnatal growth retardation | DMXL2 ERCC6 SYNE1 SPTA1 PTPN22 KIF15 SETBP1 PLAG1 PLAGL1 KDM6A PCNT TRAPPC2 | 1.42e-06 | 258 | 45 | 12 | HP:0008897 |
| HumanPheno | Abnormal hand epiphysis morphology | 1.07e-05 | 59 | 45 | 6 | HP:0005924 | |
| HumanPheno | Abnormal upper limb epiphysis morphology | 1.72e-05 | 64 | 45 | 6 | HP:0003839 | |
| HumanPheno | Abnormal epiphysis morphology of the phalanges of the hand | 2.86e-05 | 42 | 45 | 5 | HP:0005920 | |
| HumanPheno | Ivory epiphyses | 5.22e-05 | 9 | 45 | 3 | HP:0010583 | |
| HumanPheno | Cone-shaped epiphysis | 7.14e-05 | 82 | 45 | 6 | HP:0010579 | |
| Domain | HABP4_PAI-RBP1 | USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 | 2.91e-25 | 16 | 155 | 13 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 | 2.91e-25 | 16 | 155 | 13 | IPR006861 |
| Domain | zf-C2H2 | ATF7 ZBTB38 ZNF154 ZNF155 ZNF157 TRPS1 ZNF189 ZNF521 ZNF343 ZNF200 REST ZNF112 ZNF235 PRDM4 CHAMP1 ZNF623 CASZ1 ZBTB24 ZFX ZNF711 RLF ZNF106 ZNF600 ZNF713 ZNF28 ZNF33A ZNF556 ZNF451 ZFP91 ZBTB40 ZNF432 ZNF814 PLAGL1 PLAGL2 ZFHX3 ZNF81 ZNF606 PRDM16 ZNF292 | 6.84e-22 | 693 | 155 | 39 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | ATF7 ZBTB38 ZNF154 ZNF155 ZNF157 TRPS1 ZNF189 ZNF521 ZNF343 ZNF200 REST ZNF112 ZNF235 PRDM4 CHAMP1 ZNF623 CASZ1 ZBTB24 ZFX ZNF711 RLF ZNF106 ZNF600 ZNF713 ZNF28 ZNF33A ZNF556 ZNF451 ZFP91 ZBTB40 ZNF432 ZNF814 PLAG1 PLAGL1 PLAGL2 ZFHX3 ZNF81 ZNF606 PRDM16 ZNF292 | 4.30e-21 | 775 | 155 | 40 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ATF7 ZBTB38 ZNF154 ZNF155 ZNF157 TRPS1 ZNF189 ZNF521 ZNF343 ZNF200 REST ZNF112 ZNF235 PRDM4 CHAMP1 ZNF623 CASZ1 ZBTB24 ZFX ZNF711 RLF ZNF106 ZNF600 ZNF713 ZNF28 ZNF33A ZNF556 ZNF451 ZFP91 ZBTB40 ZNF432 ZNF814 PLAG1 PLAGL1 PLAGL2 ZFHX3 ZNF81 ZNF606 PRDM16 ZNF292 | 4.72e-21 | 777 | 155 | 40 | PS00028 |
| Domain | USP_1 | USP17L7 USP53 USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 | 9.25e-21 | 70 | 155 | 17 | PS00972 |
| Domain | Znf_C2H2-like | ATF7 ZBTB38 ZNF154 ZNF155 ZNF157 TRPS1 ZNF189 ZNF521 ZNF343 ZNF200 REST ZNF112 ZNF235 PRDM4 CHAMP1 ZNF623 CASZ1 ZBTB24 ZFX ZNF711 RLF ZNF106 ZNF600 ZNF713 ZNF28 ZNF33A ZNF556 ZNF451 ZFP91 ZBTB40 ZNF432 ZNF814 PLAG1 PLAGL1 PLAGL2 ZFHX3 ZNF81 ZNF606 PRDM16 ZNF292 | 1.13e-20 | 796 | 155 | 40 | IPR015880 |
| Domain | UCH | USP17L7 USP53 USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 | 1.21e-20 | 71 | 155 | 17 | PF00443 |
| Domain | USP_2 | USP17L7 USP53 USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 | 1.21e-20 | 71 | 155 | 17 | PS00973 |
| Domain | USP_3 | USP17L7 USP53 USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 | 1.57e-20 | 72 | 155 | 17 | PS50235 |
| Domain | USP_dom | USP17L7 USP53 USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 | 1.57e-20 | 72 | 155 | 17 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP53 USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 | 1.57e-20 | 72 | 155 | 17 | IPR001394 |
| Domain | Znf_C2H2 | ATF7 ZBTB38 ZNF154 ZNF155 ZNF157 TRPS1 ZNF189 ZNF521 ZNF343 ZNF200 REST ZNF112 ZNF235 PRDM4 CHAMP1 ZNF623 CASZ1 ZBTB24 ZFX ZNF711 RLF ZNF106 ZNF600 ZNF713 ZNF28 ZNF33A ZNF556 ZNF451 ZFP91 ZBTB40 ZNF432 ZNF814 PLAG1 PLAGL1 PLAGL2 ZFHX3 ZNF81 ZNF606 PRDM16 ZNF292 | 1.69e-20 | 805 | 155 | 40 | IPR007087 |
| Domain | ZnF_C2H2 | ATF7 ZBTB38 ZNF154 ZNF155 ZNF157 TRPS1 ZNF189 ZNF521 ZNF343 ZNF200 REST ZNF112 ZNF235 PRDM4 CHAMP1 ZNF623 CASZ1 ZBTB24 ZFX ZNF711 RLF ZNF106 ZNF600 ZNF713 ZNF28 ZNF33A ZNF556 ZNF451 ZFP91 ZBTB40 ZNF432 ZNF814 PLAG1 PLAGL1 PLAGL2 ZFHX3 ZNF81 ZNF606 PRDM16 ZNF292 | 1.93e-20 | 808 | 155 | 40 | SM00355 |
| Domain | Znf_C2H2/integrase_DNA-bd | ATF7 ZBTB38 ZNF154 ZNF155 ZNF157 ZNF189 ZNF521 ZNF343 ZNF200 REST ZNF112 ZNF235 PRDM4 CHAMP1 ZNF623 ZBTB24 ZFX ZNF711 RLF ZNF600 ZNF713 ZNF28 ZNF33A ZNF556 ZFP91 ZBTB40 ZNF432 ZNF814 PLAG1 PLAGL1 PLAGL2 ZFHX3 ZNF81 ZNF606 PRDM16 ZNF292 | 4.90e-19 | 694 | 155 | 36 | IPR013087 |
| Domain | - | ATF7 ZBTB38 ZNF154 ZNF155 ZNF157 ZNF189 ZNF521 ZNF343 ZNF200 REST ZNF112 ZNF235 PRDM4 CHAMP1 ZNF623 ZBTB24 ZFX ZNF711 RLF ZNF600 ZNF28 ZNF33A ZNF556 ZFP91 ZBTB40 ZNF432 ZNF814 PLAG1 PLAGL1 PLAGL2 ZFHX3 ZNF81 ZNF606 PRDM16 ZNF292 | 2.01e-18 | 679 | 155 | 35 | 3.30.160.60 |
| Domain | USP_CS | USP17L7 USP17L21 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 | 5.71e-18 | 66 | 155 | 15 | IPR018200 |
| Domain | Groucho_enhance | 2.27e-08 | 5 | 155 | 4 | IPR009146 | |
| Domain | Spectrin | 2.66e-08 | 23 | 155 | 6 | PF00435 | |
| Domain | Spectrin_repeat | 1.20e-07 | 29 | 155 | 6 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 2.25e-07 | 32 | 155 | 6 | IPR018159 | |
| Domain | SPEC | 2.25e-07 | 32 | 155 | 6 | SM00150 | |
| Domain | KRAB | ZNF154 ZNF155 ZNF157 ZNF189 ZNF343 ZNF112 ZNF235 ZNF713 ZNF28 ZNF33A ZNF556 ZNF432 ZNF814 ZNF81 ZNF606 | 3.10e-07 | 358 | 155 | 15 | PS50805 |
| Domain | KRAB | ZNF154 ZNF155 ZNF157 ZNF189 ZNF343 ZNF112 ZNF235 ZNF713 ZNF28 ZNF33A ZNF556 ZNF432 ZNF814 ZNF81 ZNF606 | 3.10e-07 | 358 | 155 | 15 | PF01352 |
| Domain | KRAB | ZNF154 ZNF155 ZNF157 ZNF189 ZNF343 ZNF112 ZNF235 ZNF713 ZNF28 ZNF33A ZNF556 ZNF432 ZNF814 ZNF81 ZNF606 | 4.56e-07 | 369 | 155 | 15 | SM00349 |
| Domain | KRAB | ZNF154 ZNF155 ZNF157 ZNF189 ZNF343 ZNF112 ZNF235 ZNF713 ZNF28 ZNF33A ZNF556 ZNF432 ZNF814 ZNF81 ZNF606 | 4.72e-07 | 370 | 155 | 15 | IPR001909 |
| Domain | zf-C2H2_6 | ZNF154 ZNF155 ZNF157 ZNF521 ZNF200 ZBTB24 ZNF600 ZNF556 ZNF432 ZNF814 PLAGL2 ZNF606 PRDM16 | 2.25e-06 | 314 | 155 | 13 | PF13912 |
| Domain | TLE_N | 5.54e-06 | 5 | 155 | 3 | PF03920 | |
| Domain | Groucho/TLE_N | 5.54e-06 | 5 | 155 | 3 | IPR005617 | |
| Domain | Actinin_actin-bd_CS | 3.57e-05 | 23 | 155 | 4 | IPR001589 | |
| Domain | ACTININ_2 | 3.57e-05 | 23 | 155 | 4 | PS00020 | |
| Domain | ACTININ_1 | 3.57e-05 | 23 | 155 | 4 | PS00019 | |
| Domain | HCAR2/3_rcpt | 6.84e-05 | 2 | 155 | 2 | IPR028017 | |
| Domain | GRIP_dom | 1.17e-04 | 12 | 155 | 3 | IPR000237 | |
| Domain | GRIP | 1.17e-04 | 12 | 155 | 3 | PS50913 | |
| Domain | Zfx_Zfy_act | 2.04e-04 | 3 | 155 | 2 | PF04704 | |
| Domain | Transcrp_activ_Zfx/Zfy-dom | 2.04e-04 | 3 | 155 | 2 | IPR006794 | |
| Domain | Spectrin_alpha_SH3 | 2.37e-04 | 15 | 155 | 3 | IPR013315 | |
| Domain | AT_hook | 2.90e-04 | 16 | 155 | 3 | PF02178 | |
| Domain | KASH | 4.06e-04 | 4 | 155 | 2 | PF10541 | |
| Domain | KASH | 4.06e-04 | 4 | 155 | 2 | IPR012315 | |
| Domain | KASH | 4.06e-04 | 4 | 155 | 2 | PS51049 | |
| Domain | KASH | 4.06e-04 | 4 | 155 | 2 | SM01249 | |
| Domain | C2H2_Znf_fam | 9.98e-04 | 24 | 155 | 3 | IPR027775 | |
| Domain | - | 1.00e-03 | 6 | 155 | 2 | 3.90.1290.10 | |
| Domain | EF-hand_Ca_insen | 1.00e-03 | 6 | 155 | 2 | IPR014837 | |
| Domain | GAR | 1.00e-03 | 6 | 155 | 2 | PS51460 | |
| Domain | - | 1.00e-03 | 6 | 155 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 1.00e-03 | 6 | 155 | 2 | IPR003108 | |
| Domain | EFhand_Ca_insen | 1.00e-03 | 6 | 155 | 2 | PF08726 | |
| Domain | GAS2 | 1.00e-03 | 6 | 155 | 2 | PF02187 | |
| Domain | GAS2 | 1.00e-03 | 6 | 155 | 2 | SM00243 | |
| Domain | Plectin_repeat | 1.40e-03 | 7 | 155 | 2 | IPR001101 | |
| Domain | ANION_EXCHANGER_2 | 1.40e-03 | 7 | 155 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 1.40e-03 | 7 | 155 | 2 | PS00219 | |
| Domain | Plectin | 1.40e-03 | 7 | 155 | 2 | PF00681 | |
| Domain | PLEC | 1.40e-03 | 7 | 155 | 2 | SM00250 | |
| Domain | AT_hook | 1.42e-03 | 27 | 155 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.42e-03 | 27 | 155 | 3 | IPR017956 | |
| Domain | CH | 2.09e-03 | 65 | 155 | 4 | SM00033 | |
| Domain | HMGI/Y_DNA-bd_CS | 2.12e-03 | 31 | 155 | 3 | IPR000637 | |
| Domain | Band3_cytoplasmic_dom | 2.37e-03 | 9 | 155 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 2.37e-03 | 9 | 155 | 2 | PF07565 | |
| Domain | - | 2.37e-03 | 9 | 155 | 2 | 3.40.1100.10 | |
| Domain | CH | 2.74e-03 | 70 | 155 | 4 | PF00307 | |
| Domain | - | 2.88e-03 | 71 | 155 | 4 | 1.10.418.10 | |
| Domain | HCO3_cotransp | 2.95e-03 | 10 | 155 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 2.95e-03 | 10 | 155 | 2 | IPR011531 | |
| Domain | PTrfase/Anion_transptr | 2.95e-03 | 10 | 155 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 2.95e-03 | 10 | 155 | 2 | IPR003020 | |
| Domain | - | 2.95e-03 | 10 | 155 | 2 | 1.10.220.60 | |
| Domain | Prefoldin | 3.03e-03 | 72 | 155 | 4 | IPR009053 | |
| Domain | CH | 3.19e-03 | 73 | 155 | 4 | PS50021 | |
| Domain | WD40_repeat_dom | 3.42e-03 | 297 | 155 | 8 | IPR017986 | |
| Domain | CH-domain | 3.51e-03 | 75 | 155 | 4 | IPR001715 | |
| Domain | Grip | 3.58e-03 | 11 | 155 | 2 | SM00755 | |
| Domain | GRIP | 3.58e-03 | 11 | 155 | 2 | PF01465 | |
| Domain | Septin | 5.03e-03 | 13 | 155 | 2 | PF00735 | |
| Domain | G_SEPTIN_dom | 5.03e-03 | 13 | 155 | 2 | IPR030379 | |
| Domain | G_SEPTIN | 5.03e-03 | 13 | 155 | 2 | PS51719 | |
| Domain | Septin | 5.83e-03 | 14 | 155 | 2 | IPR016491 | |
| Domain | WD40 | 5.95e-03 | 259 | 155 | 7 | PF00400 | |
| Domain | WD40 | 7.13e-03 | 268 | 155 | 7 | SM00320 | |
| Domain | WD40_repeat | 7.71e-03 | 272 | 155 | 7 | IPR001680 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 8.02e-23 | 45 | 116 | 16 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 FOXO4 TNKS2 USP17L22 USP17L15 USP17L8 | 1.20e-15 | 191 | 116 | 19 | MM15289 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 FOXO4 TNKS2 USP17L22 USP17L15 USP17L8 | 2.37e-13 | 221 | 116 | 18 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 FOXO4 TNKS2 USP17L22 USP17L15 USP17L8 | 3.93e-13 | 262 | 116 | 19 | MM15286 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 FOXO4 TNKS2 USP17L22 USP17L15 USP17L8 | 3.92e-11 | 299 | 116 | 18 | M27574 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 SPTA1 SPTAN1 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.08e-10 | 318 | 116 | 18 | MM15278 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L7 USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 SPTA1 SPTAN1 USP17L5 USP17L19 DBT APP USP17L18 MGAT5 USP17L17 USP17L6P USP17L3 HRC FOXO4 TNKS2 USP17L22 USP17L15 USP17L8 TRAPPC2 | 4.86e-05 | 1389 | 116 | 26 | MM15307 |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 6.25e-05 | 10 | 116 | 3 | MM15156 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | HDAC5 ZNF154 ZNF155 ZNF157 ZNF189 ZNF521 ZNF343 ZNF200 REST ZNF112 ZNF235 JMY ZNF711 ZNF600 ZNF713 ZNF28 ZNF33A ZNF556 NUAK1 INTS13 ZNF432 PLAGL1 FOXO4 ZFHX3 ZNF606 | 1.29e-04 | 1387 | 116 | 25 | M734 |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 1.85e-04 | 14 | 116 | 3 | M27402 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 USP17L4 USP17L2 USP22 USP17L12 USP17L20 USP17L11 SPTA1 SPTAN1 USP17L24 USP17L5 USP17L19 DBT APP USP17L18 MGAT5 USP17L17 USP17L3 HRC FOXO4 TNKS2 USP17L22 USP17L15 USP17L8 TRAPPC2 | 3.36e-04 | 1475 | 116 | 25 | M19806 |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 6.41e-04 | 48 | 116 | 4 | M611 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 4.57e-34 | 21 | 162 | 16 | 8622927 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 4.57e-34 | 21 | 162 | 16 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 4.57e-34 | 21 | 162 | 16 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 4.57e-34 | 21 | 162 | 16 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 4.57e-34 | 21 | 162 | 16 | 12447969 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 4.57e-34 | 21 | 162 | 16 | 18980247 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.67e-33 | 22 | 162 | 16 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.63e-32 | 24 | 162 | 16 | 8995226 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 4.52e-32 | 25 | 162 | 16 | 21115691 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.05e-31 | 33 | 162 | 17 | 20228807 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.17e-31 | 26 | 162 | 16 | 35816173 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.10e-31 | 34 | 162 | 17 | 20403174 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.10e-31 | 34 | 162 | 17 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.10e-31 | 34 | 162 | 17 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.10e-31 | 34 | 162 | 17 | 19188362 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.10e-31 | 34 | 162 | 17 | 11941478 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.10e-31 | 34 | 162 | 17 | 17109758 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.10e-31 | 34 | 162 | 17 | 20388806 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.10e-31 | 34 | 162 | 17 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.10e-31 | 34 | 162 | 17 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.10e-31 | 34 | 162 | 17 | 20368735 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.10e-31 | 34 | 162 | 17 | 10936051 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 2.10e-31 | 34 | 162 | 17 | 21448158 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 4.07e-31 | 35 | 162 | 17 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 4.07e-31 | 35 | 162 | 17 | 21239494 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 7.68e-31 | 36 | 162 | 17 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.41e-30 | 37 | 162 | 17 | 20228808 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.48e-30 | 29 | 162 | 16 | 32527007 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 9.86e-26 | 50 | 162 | 16 | 31806660 |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 4.95e-15 | 10 | 162 | 7 | 24207026 | |
| Pubmed | 3.24e-14 | 12 | 162 | 7 | 24695638 | ||
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 1.39e-13 | 14 | 162 | 7 | 11793228 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 TRPS1 ZNF521 USP17L5 USP17L19 ZNF235 USP17L18 ZNF711 USP17L17 USP17L6P USP17L3 USP17L22 KDM6A USP17L15 USP17L8 TRAPPC2 | 9.63e-13 | 674 | 162 | 22 | 37196079 | |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | 2.01e-12 | 19 | 162 | 7 | 28067227 | |
| Pubmed | DMXL2 HDAC5 SYNE1 ZBTB24 SULF2 DST TRIM9 SETBP1 SYNE2 ZBTB40 MACF1 PRDM16 PCNT | 5.45e-11 | 225 | 162 | 13 | 12168954 | |
| Pubmed | INTS6L SYNE1 SPTAN1 SYBU CCDC88A DST STX18 TRIM9 ZNF451 MACF1 GOLGA4 | 1.46e-10 | 151 | 162 | 11 | 17043677 | |
| Pubmed | DMXL2 ZBTB38 SYNE1 SPTAN1 TRPS1 ZNF189 ZNF521 ZNF343 APP PRDM4 BATF2 CIT TRIP11 DST SEPTIN3 STX18 TRIM9 ZNF451 LRRCC1 MACF1 TNKS2 ZNF606 KDM6A ZNF292 ARMC8 PCNT | 3.01e-10 | 1285 | 162 | 26 | 35914814 | |
| Pubmed | HDAC5 ZFYVE16 TRPS1 INPP5F CHAMP1 RLF CCDC88A DST KIF15 GCC2 TLE1 TLE3 TLE4 ZFHX3 PCNT | 1.34e-09 | 418 | 162 | 15 | 34709266 | |
| Pubmed | USP53 ZSCAN12 BMS1 LMTK2 KIAA1549 INPP5F DDX55 CHAMP1 SEPTIN8 SULF2 CCDC88A DST NUAK1 TRIM9 SETBP1 PLAGL2 | 4.27e-09 | 529 | 162 | 16 | 14621295 | |
| Pubmed | USP17L7 USP17L4 USP17L2 USP22 USP17L6P USP17L3 USP17L15 USP17L8 | 4.49e-09 | 81 | 162 | 8 | 12838346 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 HDAC5 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 NUAK1 USP17L17 | 5.15e-09 | 119 | 162 | 9 | 28625976 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 5.55e-09 | 120 | 162 | 9 | 31413325 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | ATF7 ZBTB38 ZNF157 TRPS1 KIAA1549 ZNF200 REST PRDM4 BATF2 ZBTB24 ZFX ZNF711 ZNF28 ZNF451 SETBP1 PLAG1 PLAGL1 PLAGL2 FOXO4 ZFHX3 | 1.01e-08 | 908 | 162 | 20 | 19274049 |
| Pubmed | TRPS1 ZNF521 REST ZNF235 PRDM4 CHAMP1 ZFX RLF BAZ2A TRIM9 MACF1 PLAG1 PLAGL2 FOXO4 ZFHX3 PRDM16 ZNF292 | 4.14e-08 | 709 | 162 | 17 | 22988430 | |
| Pubmed | ATF7 ZSCAN12 TRPS1 REST ZNF235 PRDM4 ZNF623 ZC3H6 ZBTB24 BAZ2A TLE3 ZNF451 PLAG1 PLAGL2 ZFHX3 PRDM16 KDM6A ZNF292 | 4.91e-08 | 808 | 162 | 18 | 20412781 | |
| Pubmed | Tle corepressors are differentially partitioned to instruct CD8+ T cell lineage choice and identity. | 9.92e-08 | 3 | 162 | 3 | 30045946 | |
| Pubmed | Transcriptional activation capacity of the novel PLAG family of zinc finger proteins. | 9.92e-08 | 3 | 162 | 3 | 9722527 | |
| Pubmed | ATP5IF1 ZFYVE16 SPTAN1 TRPS1 BMS1 LMTK2 KIAA1549 PTPN22 SLC39A10 DBT APP KIAA0753 CCDC88A KIF15 TLE3 SYNE2 CEP135 KDM6A GOLGA4 PCNT | 1.07e-07 | 1049 | 162 | 20 | 27880917 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | HDAC5 TRPS1 ZNF521 DBT APP RLF TLE1 TLE3 TLE4 ZFHX3 PRDM16 KDM6A | 1.07e-07 | 351 | 162 | 12 | 38297188 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | USP53 SLC4A7 USP22 SPTAN1 LMTK2 SIK1 INPP5F TRIP11 TMCC3 KIAA0753 ZNF106 CCDC88A DST TRIM9 SYNE2 MACF1 FOXO4 GOLGA4 | 1.26e-07 | 861 | 162 | 18 | 36931259 |
| Pubmed | DMXL2 ZSCAN12 SLC4A8 SYNE1 SPTAN1 SH3GL2 CIT TRIP11 RTN1 CCDC88A DST SEPTIN3 KIF15 SYNE2 STRN4 MACF1 GOLGA4 ARMC8 PCNT | 1.35e-07 | 963 | 162 | 19 | 28671696 | |
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 8645603 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 11290324 | ||
| Pubmed | 5.69e-07 | 103 | 162 | 7 | 10574462 | ||
| Pubmed | FLG USP22 HDAC5 SPTAN1 TRPS1 BMS1 ZNF521 DBT CIT RLF DST TRIM9 TLE1 TLE3 TLE4 ZNF451 SYNE2 ZFP91 ZBTB40 ZFHX3 PRDM16 KDM6A | 8.98e-07 | 1429 | 162 | 22 | 35140242 | |
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 1303260 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 8365415 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 8989517 | ||
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 8573724 | ||
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 8892234 | ||
| Pubmed | Repression of the Transactivating Capacity of the Oncoprotein PLAG1 by SUMOylation. | 1.96e-06 | 6 | 162 | 3 | 15208321 | |
| Pubmed | 2.07e-06 | 20 | 162 | 4 | 21689717 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | KNTC1 TRPS1 APP CASZ1 TLE1 TLE3 SYNE2 TNKS2 PRDM16 KDM6A ZNF292 | 2.93e-06 | 398 | 162 | 11 | 35016035 |
| Pubmed | A Gro/TLE-NuRD corepressor complex facilitates Tbx20-dependent transcriptional repression. | 3.42e-06 | 7 | 162 | 3 | 24024827 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 16314515 | ||
| Pubmed | HDAC5 ZFYVE16 SYNE1 SLC39A10 BAZ2A GCC2 TLE3 TLE4 ZNF451 MACF1 PCNT | 3.63e-06 | 407 | 162 | 11 | 12693553 | |
| Pubmed | DMXL2 ZBTB38 SYNE1 TRIP11 ZNF711 DST XIRP2 SYNE2 ZBTB40 MACF1 TNKS2 TRAPPC2 | 4.12e-06 | 497 | 162 | 12 | 23414517 | |
| Pubmed | ERCC6 ZFYVE16 PRDM4 RLF ZNF106 DST ZNF451 CEP135 MACF1 PLAG1 PLAGL1 TNKS2 KDM6A | 4.46e-06 | 591 | 162 | 13 | 15231748 | |
| Pubmed | Expression of Groucho/TLE proteins during pancreas development. | 4.48e-06 | 24 | 162 | 4 | 18778483 | |
| Pubmed | DMXL2 SLC4A7 ZFYVE16 ARFGEF1 SLC39A10 TRIP11 RTN1 DST STX18 SYNE2 GOLGA4 TRAPPC2 | 4.75e-06 | 504 | 162 | 12 | 34432599 | |
| Pubmed | A comparison of Notch, Hes and Grg expression during murine embryonic and post-natal development. | 5.46e-06 | 8 | 162 | 3 | 10512199 | |
| Pubmed | Nolz1 promotes striatal neurogenesis through the regulation of retinoic acid signaling. | 5.46e-06 | 8 | 162 | 3 | 20735826 | |
| Pubmed | Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9. | 5.46e-06 | 8 | 162 | 3 | 28296634 | |
| Pubmed | 5.46e-06 | 8 | 162 | 3 | 16002402 | ||
| Pubmed | DMXL2 ATP5IF1 SLC4A7 SLC4A8 SPTAN1 SH3GL2 LMTK2 DBT APP CIT RTN1 SLC25A51 SEPTIN8 CCDC88A SEPTIN3 TRIM9 STRN4 MACF1 | 6.70e-06 | 1139 | 162 | 18 | 36417873 | |
| Pubmed | 8.19e-06 | 101 | 162 | 6 | 9872452 | ||
| Pubmed | ATP5IF1 ZFYVE16 SPTAN1 DBT DDX55 ZBTB24 KIAA0753 ZNF711 RLF DST ZFP91 CEP135 PCNT | 1.13e-05 | 645 | 162 | 13 | 25281560 | |
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 16193498 | ||
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 30571765 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLG DMXL2 ZBTB38 USP22 SYNE1 SPTAN1 BMS1 ZNF521 DBT DDX55 CHAMP1 ZC3H6 SULF2 DST IRAK4 MACF1 ZNF292 | 1.32e-05 | 1082 | 162 | 17 | 38697112 |
| Pubmed | 1.47e-05 | 233 | 162 | 8 | 37704626 | ||
| Pubmed | A neurogenomics approach to gene expression analysis in the developing brain. | 1.59e-05 | 170 | 162 | 7 | 15582152 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 1.59e-05 | 11 | 162 | 3 | 15499562 | |
| Pubmed | 1.82e-05 | 69 | 162 | 5 | 32238831 | ||
| Pubmed | TRIML1 ERCC6 USP22 TRPS1 KIAA1549 CLSTN2 DBT APP CHAMP1 ZNF711 SULF2 BAZ2A INTS13 ZFP91 MACF1 ZFHX3 PRDM16 | 1.96e-05 | 1116 | 162 | 17 | 31753913 | |
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 2.12e-05 | 12 | 162 | 3 | 11266540 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 28186140 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 30154797 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 15265687 | ||
| Pubmed | The role of HCA2 (GPR109A) in regulating macrophage function. | 2.16e-05 | 2 | 162 | 2 | 23882124 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 23473036 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 36891315 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 11792814 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 11002341 | ||
| Pubmed | Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a. | 2.16e-05 | 2 | 162 | 2 | 38007572 | |
| Pubmed | Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE. | 2.16e-05 | 2 | 162 | 2 | 24691444 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 31347703 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 2.16e-05 | 2 | 162 | 2 | 24931616 | |
| Pubmed | Gro/TLE enables embryonic stem cell differentiation by repressing pluripotent gene expression. | 2.16e-05 | 2 | 162 | 2 | 25446531 | |
| Pubmed | Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis. | 2.16e-05 | 2 | 162 | 2 | 30659164 | |
| Interaction | HDAC1 interactions | MYH4 ERCC6 HDAC5 ZFYVE16 SPTAN1 TRPS1 ZNF521 ARFGEF1 REST INPP5F PRDM4 CIT CASZ1 RLF DST KIF15 BAZ2A GCC2 TLE1 TLE3 TLE4 SYNE2 CEP135 PLAGL1 ZFHX3 PRDM16 GOLGA4 PCNT | 2.04e-08 | 1108 | 154 | 28 | int:HDAC1 |
| Interaction | SOX7 interactions | 2.14e-07 | 82 | 154 | 8 | int:SOX7 | |
| Interaction | GSC interactions | 3.40e-07 | 87 | 154 | 8 | int:GSC | |
| Interaction | VSX1 interactions | 7.08e-07 | 66 | 154 | 7 | int:VSX1 | |
| Interaction | EXOC1 interactions | 1.57e-06 | 143 | 154 | 9 | int:EXOC1 | |
| Interaction | STX6 interactions | SEMG2 SLC4A7 ZFYVE16 SPTAN1 LMTK2 ARFGEF1 SLC39A10 TRIP11 CCDC88A DST STX18 GCC2 MACF1 GOLGA4 ARMC8 | 1.85e-06 | 448 | 154 | 15 | int:STX6 |
| Interaction | RAB4A interactions | DMXL2 SLC4A7 ZFYVE16 SYNE1 SPTAN1 LMTK2 ARFGEF1 KIAA1549 INPP5F SLC39A10 TRIP11 DST GCC2 SYNE2 GOLGA4 | 2.37e-06 | 457 | 154 | 15 | int:RAB4A |
| Interaction | FOXI1 interactions | 6.75e-06 | 92 | 154 | 7 | int:FOXI1 | |
| Interaction | PAX9 interactions | 7.16e-06 | 130 | 154 | 8 | int:PAX9 | |
| Interaction | SEPTIN10 interactions | 1.52e-05 | 144 | 154 | 8 | int:SEPTIN10 | |
| Interaction | PCNT interactions | DMXL2 SYNE1 SPTAN1 APP TRIP11 KIAA0753 DST CEP135 MACF1 PCNT | 1.69e-05 | 241 | 154 | 10 | int:PCNT |
| Interaction | PIBF1 interactions | 2.39e-05 | 200 | 154 | 9 | int:PIBF1 | |
| Interaction | YWHAH interactions | USP53 SLC4A7 USP22 HDAC5 SPTAN1 LMTK2 SIK1 INPP5F TRIP11 TMCC3 KIAA0753 ZNF106 CCDC88A DST NUAK1 SYNE2 CEP135 MACF1 FOXO4 GOLGA4 PCNT TRAPPC2 | 3.41e-05 | 1102 | 154 | 22 | int:YWHAH |
| Interaction | PFN1 interactions | KNTC1 ATP5IF1 HDAC5 SPTAN1 INPP5F TRIP11 JMY KIF15 GCC2 TLE1 SYNE2 MACF1 GOLGA4 PCNT | 3.75e-05 | 509 | 154 | 14 | int:PFN1 |
| Interaction | GJD3 interactions | SLC4A7 ZFYVE16 SYNE1 SPTAN1 ARFGEF1 SLC39A10 TRIP11 CCDC88A DST STX18 GCC2 SYNE2 GOLGA4 | 4.76e-05 | 454 | 154 | 13 | int:GJD3 |
| Interaction | UTP4 interactions | 4.99e-05 | 170 | 154 | 8 | int:UTP4 | |
| Interaction | EGR2 interactions | 5.20e-05 | 171 | 154 | 8 | int:EGR2 | |
| Interaction | RIPPLY1 interactions | 6.24e-05 | 55 | 154 | 5 | int:RIPPLY1 | |
| Interaction | KLF3 interactions | 6.63e-05 | 228 | 154 | 9 | int:KLF3 | |
| Interaction | PHF21A interactions | HDAC5 ZFYVE16 TRPS1 INPP5F RLF CCDC88A DST KIF15 GCC2 ZFHX3 PCNT | 6.82e-05 | 343 | 154 | 11 | int:PHF21A |
| Interaction | SIX6 interactions | 6.90e-05 | 11 | 154 | 3 | int:SIX6 | |
| Interaction | CEP63 interactions | 7.18e-05 | 179 | 154 | 8 | int:CEP63 | |
| Interaction | SH3BP5 interactions | 7.70e-05 | 30 | 154 | 4 | int:SH3BP5 | |
| Interaction | GOLGA1 interactions | 8.38e-05 | 183 | 154 | 8 | int:GOLGA1 | |
| Interaction | CCDC15 interactions | 9.15e-05 | 12 | 154 | 3 | int:CCDC15 | |
| Interaction | NUP43 interactions | BMS1 CLSTN2 DDX55 CHAMP1 CIT ZFX ZNF711 RLF CCDC88A DST BAZ2A SYNE2 ZFP91 ZFHX3 ZNF292 | 9.20e-05 | 625 | 154 | 15 | int:NUP43 |
| Interaction | EPB41L4A interactions | 1.02e-04 | 140 | 154 | 7 | int:EPB41L4A | |
| Interaction | KDM1A interactions | USP22 HDAC5 ZFYVE16 TRPS1 CAGE1 INPP5F CHAMP1 CIT ZBTB24 RLF CCDC88A DST KIF15 GCC2 TLE3 TLE4 ZNF451 ZFHX3 PCNT | 1.06e-04 | 941 | 154 | 19 | int:KDM1A |
| Interaction | STX4 interactions | SLC4A7 SYNE1 SPTAN1 SLC39A10 APP TRIP11 RTN1 TMCC3 CCDC88A STX18 SYNE2 GOLGA4 | 1.14e-04 | 428 | 154 | 12 | int:STX4 |
| Interaction | DISC1 interactions | SYNE1 SPTAN1 SYBU CIT TRIP11 CEP164 CCDC88A DST STX18 MACF1 TNKS2 PCNT | 1.17e-04 | 429 | 154 | 12 | int:DISC1 |
| Interaction | ZNF235 interactions | 1.18e-04 | 13 | 154 | 3 | int:ZNF235 | |
| Interaction | NDC80 interactions | CAGE1 CEP164 KIAA0753 KIF15 GCC2 SYNE2 CEP135 LRRCC1 FAM118B PCNT | 1.47e-04 | 312 | 154 | 10 | int:NDC80 |
| Interaction | LATS1 interactions | MYH4 SPTAN1 KIAA1549 REST DBT APP TRIP11 KIAA0753 CCDC88A NUAK1 XIRP2 PCNT | 1.48e-04 | 440 | 154 | 12 | int:LATS1 |
| Interaction | GATA2 interactions | 1.50e-04 | 199 | 154 | 8 | int:GATA2 | |
| Interaction | GJA1 interactions | SLC4A7 ZFYVE16 SPTAN1 LMTK2 ARFGEF1 KIAA1549 SLC39A10 TRIP11 CCDC88A DST GCC2 SYNE2 MACF1 GOLGA4 | 1.58e-04 | 583 | 154 | 14 | int:GJA1 |
| Interaction | FEV interactions | 1.72e-04 | 203 | 154 | 8 | int:FEV | |
| Interaction | TNIK interactions | SYNE1 SPTAN1 SH3GL2 CIT DST SEPTIN3 INTS13 SYNE2 STRN4 MACF1 GOLGA4 | 1.72e-04 | 381 | 154 | 11 | int:TNIK |
| Interaction | FLT3 interactions | KNTC1 USP17L21 HDAC5 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 NUAK1 USP17L17 | 1.72e-04 | 318 | 154 | 10 | int:FLT3 |
| Interaction | ZFPL1 interactions | SLC4A7 SPTAN1 LMTK2 KIAA1549 SLC39A10 TRIP11 IVL CCDC88A DST GCC2 ATP12A GOLGA4 | 1.75e-04 | 448 | 154 | 12 | int:ZFPL1 |
| Interaction | RAB9A interactions | SLC4A7 ZFYVE16 LMTK2 ARFGEF1 KIAA1549 INPP5F SLC39A10 TRIP11 RTN1 DST STX18 GCC2 SYNE2 GOLGA4 | 1.95e-04 | 595 | 154 | 14 | int:RAB9A |
| Interaction | YWHAG interactions | USP53 SLC4A7 USP22 HDAC5 SPTAN1 LMTK2 SIK1 INPP5F APP TRIP11 TMCC3 KIAA0753 ZNF106 CCDC88A DST KIF15 NUAK1 GCC2 SYNE2 MACF1 FOXO4 TRAPPC2 | 2.08e-04 | 1248 | 154 | 22 | int:YWHAG |
| Interaction | PAX8 interactions | 2.11e-04 | 111 | 154 | 6 | int:PAX8 | |
| Interaction | ODF2 interactions | 2.16e-04 | 158 | 154 | 7 | int:ODF2 | |
| Interaction | TBR1 interactions | 2.33e-04 | 113 | 154 | 6 | int:TBR1 | |
| Interaction | DTNBP1 interactions | 2.52e-04 | 162 | 154 | 7 | int:DTNBP1 | |
| Cytoband | 4p16.1 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 | 1.03e-16 | 79 | 162 | 12 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 STX18 USP17L17 USP17L6P USP17L22 USP17L15 | 1.53e-12 | 222 | 162 | 13 | chr4p16 |
| Cytoband | 12q24.31 | 1.92e-04 | 80 | 162 | 4 | 12q24.31 | |
| Cytoband | 8p23.1 | 2.28e-04 | 154 | 162 | 5 | 8p23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF154 ZNF155 ZNF112 ZNF235 TRAPPC2B ZNF600 ZNF28 STRN4 ZNF432 HRC ZNF814 ZNF606 | 1.13e-03 | 1192 | 162 | 12 | chr19q13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 1.51e-03 | 234 | 162 | 5 | chr8p23 | |
| Cytoband | Xp11.2 | 2.26e-03 | 20 | 162 | 2 | Xp11.2 | |
| Cytoband | 17p11.2 | 2.51e-03 | 159 | 162 | 4 | 17p11.2 | |
| Cytoband | 19q13.41 | 2.70e-03 | 78 | 162 | 3 | 19q13.41 | |
| Cytoband | 19q13.4 | 2.80e-03 | 79 | 162 | 3 | 19q13.4 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZBTB38 ZSCAN12 ZNF154 ZNF155 ZNF157 TRPS1 ZNF189 ZNF521 ZNF343 ZNF200 ZNF112 ZNF235 PRDM4 CHAMP1 ZNF623 CASZ1 ZBTB24 ZFX ZNF711 RLF ZNF106 ZNF600 ZNF713 ZNF28 ZNF33A ZNF556 ZNF451 ZFP91 ZBTB40 ZNF432 ZNF814 PLAG1 PLAGL1 PLAGL2 ZFHX3 ZNF81 ZNF606 PRDM16 ZNF292 | 1.04e-27 | 718 | 106 | 39 | 28 |
| GeneFamily | Hydroxy-carboxylic acid receptors | 1.02e-04 | 3 | 106 | 2 | 200 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 2.03e-04 | 4 | 106 | 2 | 1252 | |
| GeneFamily | EF-hand domain containing|Spectrins | 7.01e-04 | 7 | 106 | 2 | 1113 | |
| GeneFamily | EF-hand domain containing|Plakins | 9.32e-04 | 8 | 106 | 2 | 939 | |
| GeneFamily | EF-hand domain containing | 1.84e-03 | 219 | 106 | 6 | 863 | |
| GeneFamily | Septins | 2.55e-03 | 13 | 106 | 2 | 732 | |
| GeneFamily | Integrator complex | 3.40e-03 | 15 | 106 | 2 | 1366 | |
| GeneFamily | Ubiquitin specific peptidases | 4.33e-03 | 56 | 106 | 3 | 366 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 4.37e-03 | 17 | 106 | 2 | 1197 | |
| GeneFamily | WD repeat domain containing | 4.46e-03 | 262 | 106 | 6 | 362 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.28e-19 | 86 | 161 | 16 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 PLAGL2 USP17L22 USP17L15 USP17L8 | 3.46e-19 | 112 | 161 | 17 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 3.65e-15 | 160 | 161 | 16 | MM1155 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L7 TPMT USP17L21 USP17L4 SLC4A7 USP17L2 USP17L12 USP17L20 USP17L11 LMTK2 USP17L5 PTPN22 USP17L19 REST APP DDX55 USP17L18 STX18 USP17L17 XIRP2 INTS13 USP17L6P USP17L3 ZNF814 USP17L22 KDM6A USP17L15 USP17L8 TRAPPC2 | 2.28e-10 | 1198 | 161 | 29 | MM1062 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L7 USP17L21 USP17L4 ATP5IF1 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 PTPN22 USP17L19 REST SLC39A10 USP17L18 USP17L17 INTS13 TLE3 USP17L6P USP17L3 USP17L22 KDM6A USP17L15 USP17L8 ARMC8 | 4.32e-08 | 1072 | 161 | 24 | MM1031 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DMXL2 SLC4A7 ZFYVE16 ARFGEF1 INPP5F APP RLF MGAT5 DST NUAK1 GCC2 TLE1 TLE4 ZNF451 SYNE2 CEP135 MACF1 ZFHX3 GOLGA4 ZNF292 PCNT | 7.22e-08 | 856 | 161 | 21 | M4500 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | DMXL2 ZBTB38 SLC4A7 SH3GL2 SYBU INPP5F PRDM4 TRIP11 ZC3H6 TMCC3 ZNF106 DST TRIM9 GCC2 SETBP1 SYNE2 PLAGL1 TNKS2 MCUB GOLGA4 ZNF292 | 3.77e-07 | 946 | 161 | 21 | M39169 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 DBT USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 5.42e-07 | 647 | 161 | 17 | MM981 |
| Coexpression | OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN | ZSCAN12 PTPN22 DBT APP ZFX RLF IRAK4 PLAG1 ZNF292 ARMC8 TRAPPC2 | 1.42e-06 | 281 | 161 | 11 | M7089 |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 3.96e-06 | 198 | 161 | 9 | M7610 | |
| Coexpression | GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_UP | 2.89e-05 | 195 | 161 | 8 | M8140 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TPMT ZSCAN12 SLC4A7 SLC4A8 TRPS1 KIAA1549 CA14 BATF2 CIT RTN1 ZNF711 CCDC88A SEPTIN3 KIF15 INTS13 GCC2 TLE1 TLE4 SETBP1 SYNE2 CEP135 LRRCC1 MACF1 ZFHX3 ZNF606 PRDM16 ZNF292 | 8.97e-07 | 1459 | 140 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | SLC4A7 SLC4A8 CIT CCDC88A KIF15 GCC2 SETBP1 SYNE2 CEP135 KDM6A GOLGA4 ZNF292 | 1.08e-06 | 311 | 140 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | ZSCAN12 SLC4A7 SLC4A8 TRPS1 KIAA1549 CLSTN2 CIT RTN1 ZNF711 CCDC88A SEPTIN3 KIF15 GCC2 TLE4 SETBP1 SYNE2 CEP135 LRRCC1 MACF1 ZNF606 PRDM16 ZNF292 | 1.71e-06 | 1060 | 140 | 22 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPMT ZSCAN12 SLC4A7 SLC4A8 TRPS1 KIAA1549 CIT ZNF711 CCDC88A SEPTIN3 KIF15 INTS13 GCC2 TLE1 TLE4 SETBP1 SYNE2 CEP135 LRRCC1 MACF1 ZFHX3 ZNF606 PRDM16 ZNF292 | 2.34e-06 | 1257 | 140 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | TPMT KNTC1 ZSCAN12 SLC4A8 SPTAN1 ZNF521 CLSTN2 RTN1 ZNF711 SULF2 CCDC88A SEPTIN3 KIF15 NUAK1 GCC2 TLE3 TLE4 SETBP1 SYNE2 CEP135 LRRCC1 PLAGL2 ZNF606 PRDM16 KDM6A | 3.13e-06 | 1370 | 140 | 25 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.45e-06 | 233 | 140 | 10 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ZSCAN12 SLC4A7 TRPS1 KIAA1549 SLC39A10 CIT KIAA0753 ZNF711 SULF2 CCDC88A SEPTIN3 KIF15 INTS13 GCC2 SYNE2 CEP135 LRRCC1 ZFHX3 ZNF606 PRDM16 KDM6A ZNF292 TRAPPC2 | 7.39e-06 | 1252 | 140 | 23 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | CLSTN2 CIT ZNF711 RLF TRIM9 TLE3 ZNF451 SYNE2 ZNF606 PRDM16 KDM6A | 1.01e-05 | 323 | 140 | 11 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | ZSCAN12 SLC4A7 SLC4A8 SH3GL2 TRPS1 KIAA1549 CA14 CLSTN2 CIT RTN1 ZNF711 CCDC88A SEPTIN3 KIF15 GCC2 TLE4 SETBP1 SYNE2 CEP135 LRRCC1 MACF1 ZNF606 PRDM16 ZNF292 | 1.70e-05 | 1414 | 140 | 24 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | INTS6L USP53 DMXL2 TRPS1 SYBU REST CIT ZFX ZNF711 RLF TRIM9 ZNF451 SYNE2 ZFHX3 ZNF606 KDM6A SMC1B | 2.28e-05 | 804 | 140 | 17 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.92e-05 | 90 | 140 | 6 | gudmap_developingGonad_P2_epididymis_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | DMXL2 ZBTB38 ZSCAN12 SLC4A8 CIT CEP164 SEPTIN8 CCDC88A KIF15 TRIM9 SETBP1 SYNE2 CEP135 STRN4 KDM6A GOLGA4 ZNF292 | 3.45e-05 | 831 | 140 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | INTS6L DMXL2 ZNF521 ZC3H6 ZNF600 CCDC88A DST SYNE2 LRRCC1 PLAG1 PRDM16 | 8.70e-05 | 409 | 140 | 11 | GSM476663_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | INTS6L SPTA1 CLSTN2 REST CIT ZFX ZNF711 RLF TRIM9 TLE3 ZNF451 SYNE2 ZFHX3 ZNF606 PRDM16 KDM6A | 9.65e-05 | 815 | 140 | 16 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.65e-04 | 298 | 140 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | SPTA1 TRPS1 ESRP1 ZNF521 KIAA1549 ZC3H6 ZFX ZNF600 DST NUAK1 TLE4 ZFP91 PLAG1 ZFHX3 TNKS2 | 1.73e-04 | 769 | 140 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | INTS6L USP53 DMXL2 ESRP1 CLSTN2 SYBU REST TMCC3 ZNF711 RLF SYNE2 TLE6 PRDM16 KDM6A SMC1B | 1.96e-04 | 778 | 140 | 15 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | TPMT DMXL2 ZBTB38 ZSCAN12 SLC4A8 CIT CEP164 SEPTIN8 CCDC88A GCC2 SYNE2 STRN4 ZNF814 MACF1 KDM6A | 2.02e-04 | 780 | 140 | 15 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | 2.14e-04 | 379 | 140 | 10 | gudmap_developingGonad_P2_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | 2.28e-04 | 382 | 140 | 10 | gudmap_developingGonad_e14.5_ ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 2.53e-04 | 387 | 140 | 10 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | INTS6L TRPS1 KERA CLSTN2 REST INPP5F ZNF711 RLF SULF2 TRIM9 TLE3 ZNF451 SYNE2 ZFHX3 KDM6A | 2.68e-04 | 801 | 140 | 15 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | SLC4A7 SLC4A8 ERCC6 TRPS1 CA14 CLSTN2 ZNF235 CIT RTN1 KIF15 GCC2 SETBP1 SYNE2 LRRCC1 MACF1 PRDM16 ZNF292 | 2.73e-04 | 986 | 140 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.89e-04 | 192 | 140 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.11e-04 | 138 | 140 | 6 | gudmap_developingGonad_e12.5_epididymis_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | INTS6L SPTA1 CLSTN2 ZNF711 RLF TRIM9 SYNE2 ZFHX3 ZNF606 KDM6A | 4.55e-04 | 417 | 140 | 10 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.60e-04 | 97 | 140 | 5 | gudmap_developingGonad_e18.5_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.89e-04 | 275 | 140 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | INTS6L KNTC1 SPTA1 ZNF521 ZNF600 KIF15 SETBP1 LRRCC1 PLAG1 PRDM16 | 5.09e-04 | 423 | 140 | 10 | GSM791126_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500 | 5.53e-04 | 101 | 140 | 5 | gudmap_developingGonad_e14.5_ ovary_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | USP53 DMXL2 ESRP1 CLSTN2 SYBU REST TMCC3 RLF TRIM9 SYNE2 TLE6 MCUB KDM6A SMC1B | 5.78e-04 | 770 | 140 | 14 | gudmap_developingGonad_P2_ovary_1000 |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | USP53 ARFGEF1 REST TRIP11 ZNF106 DST GCC2 SYNE2 GOLGA4 ZNF292 | 2.15e-09 | 199 | 155 | 10 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-07 | 182 | 155 | 8 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-07 | 184 | 155 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-07 | 185 | 155 | 8 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 4.83e-07 | 198 | 155 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.02e-07 | 199 | 155 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 5.02e-07 | 199 | 155 | 8 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 5.02e-07 | 199 | 155 | 8 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.21e-07 | 200 | 155 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-06 | 169 | 155 | 7 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-06 | 176 | 155 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.09e-06 | 186 | 155 | 7 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.71e-06 | 190 | 155 | 7 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.40e-06 | 194 | 155 | 7 | 24837a27b0041fe8c348225fa8b09b127d743603 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.58e-06 | 195 | 155 | 7 | 5812b1615676f3b77eb4769216b98b360c417c0d | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.97e-06 | 197 | 155 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 6.37e-06 | 199 | 155 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 6.37e-06 | 199 | 155 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 6.37e-06 | 199 | 155 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.59e-06 | 200 | 155 | 7 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 6.59e-06 | 200 | 155 | 7 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.59e-06 | 200 | 155 | 7 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 6.59e-06 | 200 | 155 | 7 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 8.96e-06 | 138 | 155 | 6 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 1.80e-05 | 156 | 155 | 6 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.44e-05 | 175 | 155 | 6 | a84965d28438a4228d841b357c2cd75cf4b59a63 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-05 | 175 | 155 | 6 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.66e-05 | 177 | 155 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 178 | 155 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 4.02e-05 | 180 | 155 | 6 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.69e-05 | 185 | 155 | 6 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | ASK440-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.83e-05 | 186 | 155 | 6 | ce8e63057a99afa0a9cbf27ae7f9a70c0e972b6d | |
| ToppCell | CF|World / Disease state, Lineage and Cell class | 4.97e-05 | 187 | 155 | 6 | eec4d4e4a658e3a61c05745167a1a5e3d39bb43e | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.97e-05 | 187 | 155 | 6 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 4.97e-05 | 187 | 155 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.43e-05 | 190 | 155 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 5.59e-05 | 191 | 155 | 6 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.59e-05 | 191 | 155 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.76e-05 | 192 | 155 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.76e-05 | 192 | 155 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.93e-05 | 193 | 155 | 6 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.93e-05 | 193 | 155 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.93e-05 | 193 | 155 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.93e-05 | 193 | 155 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.93e-05 | 193 | 155 | 6 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.93e-05 | 193 | 155 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic|Liver / Manually curated celltypes from each tissue | 6.10e-05 | 194 | 155 | 6 | e6391bc7073831847c469ef0b0c437118e1f151f | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 6.27e-05 | 195 | 155 | 6 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 195 | 155 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 195 | 155 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.45e-05 | 196 | 155 | 6 | c100967851f037b3522130a9e2a4175ad593ecbc | |
| ToppCell | Healthy/Control-CD8+_Tem|World / Disease group and Cell class | 6.45e-05 | 196 | 155 | 6 | a6dc92476156a695e15373ea57dc04e30014ac55 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.64e-05 | 197 | 155 | 6 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.64e-05 | 197 | 155 | 6 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.64e-05 | 197 | 155 | 6 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | T_cells-CTLs|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 6.64e-05 | 197 | 155 | 6 | 28117cf300e169182571fbad0de1681a484a435a | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.64e-05 | 197 | 155 | 6 | f45a93b5ad80a16b760acbaa6467648ffc05a0d3 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 6.83e-05 | 198 | 155 | 6 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.83e-05 | 198 | 155 | 6 | e76061e66f6d60f5735962aa7777dda8958caed9 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 7.02e-05 | 199 | 155 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 7.02e-05 | 199 | 155 | 6 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 7.02e-05 | 199 | 155 | 6 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | IPF-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 7.02e-05 | 199 | 155 | 6 | 3c2b362d5e824e1a04830e70352f8818de984174 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 7.02e-05 | 199 | 155 | 6 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.02e-05 | 199 | 155 | 6 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.02e-05 | 199 | 155 | 6 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.22e-05 | 200 | 155 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | mild-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.22e-05 | 200 | 155 | 6 | 86f585bf9066b179bbcbc703bf43f15da4a07284 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 7.22e-05 | 200 | 155 | 6 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 7.22e-05 | 200 | 155 | 6 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 7.22e-05 | 200 | 155 | 6 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.22e-05 | 200 | 155 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.22e-05 | 200 | 155 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.22e-05 | 200 | 155 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 7.22e-05 | 200 | 155 | 6 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.10e-04 | 135 | 155 | 5 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 1.18e-04 | 137 | 155 | 5 | a1e34ebbeda3d5a4f14917282d44fcb4dcbf3133 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-04 | 155 | 155 | 5 | 4559e3011514041b65c17ae4ede29da202bce14c | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-04 | 156 | 155 | 5 | d9d87368e43b24952e70f31f38425e15b716ff5b | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-gdT|Leuk-UTI / Disease, Lineage and Cell Type | 2.29e-04 | 158 | 155 | 5 | c4b0af25608cee3d0d2b0193f5ff45d9dc87078b | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.29e-04 | 158 | 155 | 5 | 2af7beb48272e5368d9ba6b80f08d47ab8556c08 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.36e-04 | 159 | 155 | 5 | bf8ff9251bcb64b2b9d6dd93461aec97659686ec | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.50e-04 | 161 | 155 | 5 | 8aaca49b53a551395f4025ac4e535c7b0ce41a49 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.50e-04 | 161 | 155 | 5 | deb10628d258fb813c293f81fb71be8e383dc82a | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue | 2.50e-04 | 161 | 155 | 5 | 2f068ee643de2f647c289779a6624265ab9a749b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 162 | 155 | 5 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-3|TCGA-Uterus / Sample_Type by Project: Shred V9 | 2.65e-04 | 163 | 155 | 5 | d64dd39b077105c73e570ccef70f0e74a2c586ac | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.65e-04 | 163 | 155 | 5 | 0ab043b68e8739adcedda01165a3758cd0d22728 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.96e-04 | 167 | 155 | 5 | 9526e2c7673d569d04e0728a2526318e67432e0a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.96e-04 | 167 | 155 | 5 | b0eb7a40491dd2432f5282f578ce569df86d21a7 | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 3.21e-04 | 170 | 155 | 5 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.21e-04 | 170 | 155 | 5 | 7bba77ae34a0259fad6ee98cf665ff50f77a1328 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.21e-04 | 170 | 155 | 5 | a43b977a7fe745536cf96b7c080397d9fa73086b | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.30e-04 | 171 | 155 | 5 | 1018d7bd378ce20bee56a77d5851b3538c55098c | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.30e-04 | 171 | 155 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)-DC1_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.30e-04 | 171 | 155 | 5 | 6bda333bb751d7835a04f21ac959eea79f2516aa | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.30e-04 | 171 | 155 | 5 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.30e-04 | 171 | 155 | 5 | 173bb5318fdbaef6e695b6f9e3e0ff4a5432a1a4 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-04 | 172 | 155 | 5 | a125ac2db9c8ece95970a93aa6f7918d1dcef886 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-04 | 172 | 155 | 5 | 6aab59add5b180cee0ca31179c620e89d352d5c1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.50e-06 | 49 | 87 | 6 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.92e-05 | 50 | 87 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes in the cancer module 123. | 1.66e-04 | 247 | 87 | 9 | MODULE_123 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.43e-04 | 49 | 87 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_3 | |
| Computational | Neighborhood of BCL2L11 | 7.55e-04 | 186 | 87 | 7 | MORF_BCL2L11 | |
| Drug | vinylene | TRPS1 ZNF200 CLSTN2 REST ZNF235 ZBTB24 ZFX ZNF33A PLAG1 PLAGL2 ZNF81 ZNF606 | 7.95e-08 | 245 | 149 | 12 | CID000006326 |
| Drug | Mitoxantrone dihydrochloride [70476-82-3]; Down 200; 7.8uM; MCF7; HT_HG-U133A | TRAF5 SPTAN1 ZNF189 ZNF623 ZBTB24 RLF KIF15 ZBTB40 PLAGL2 ZNF292 | 3.66e-07 | 183 | 149 | 10 | 3232_DN |
| Drug | Avermectin B1 [71751-41-2]; Down 200; 4.8uM; PC3; HT_HG-U133A | 6.48e-06 | 198 | 149 | 9 | 5864_DN | |
| Drug | Thiorphan [76721-89-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 6.75e-06 | 199 | 149 | 9 | 6249_DN | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 1.29e-05 | 164 | 149 | 8 | 3963_UP | |
| Drug | Clorgyline | 1.53e-05 | 168 | 149 | 8 | ctd:D003010 | |
| Drug | plakin | 1.65e-05 | 82 | 149 | 6 | CID000018752 | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.14e-05 | 176 | 149 | 8 | 6980_DN | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 1.54e-27 | 46 | 158 | 17 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 | 4.74e-24 | 69 | 158 | 17 | DOID:1682 (implicated_via_orthology) |
| Disease | 1-stearoylglycerol 1-monostearin measurement | 2.85e-05 | 2 | 158 | 2 | EFO_0021111 | |
| Disease | X-linked spondyloepiphyseal dysplasia tarda (implicated_via_orthology) | 2.85e-05 | 2 | 158 | 2 | DOID:0080362 (implicated_via_orthology) | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 1.70e-04 | 4 | 158 | 2 | cv:CN293514 | |
| Disease | Premature aging syndrome | 1.70e-04 | 4 | 158 | 2 | C0231341 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 2.82e-04 | 5 | 158 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 2.82e-04 | 5 | 158 | 2 | C0410190 | |
| Disease | Emery-Dreifuss muscular dystrophy | 4.21e-04 | 6 | 158 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 4.21e-04 | 6 | 158 | 2 | C0410189 | |
| Disease | spondyloepiphyseal dysplasia congenita (implicated_via_orthology) | 4.21e-04 | 6 | 158 | 2 | DOID:14789 (implicated_via_orthology) | |
| Disease | peripheral neuropathy | 5.88e-04 | 7 | 158 | 2 | EFO_0003100 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 5.88e-04 | 7 | 158 | 2 | C0751337 | |
| Disease | phosphatidylcholine 38:2 measurement | 8.69e-04 | 35 | 158 | 3 | EFO_0010384 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.01e-03 | 291 | 158 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.82e-03 | 12 | 158 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | urgency urinary incontinence | 1.82e-03 | 12 | 158 | 2 | EFO_0006865 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 2.14e-03 | 13 | 158 | 2 | C3501611 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.32e-03 | 103 | 158 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | caudate volume change measurement | 2.49e-03 | 14 | 158 | 2 | EFO_0021491 | |
| Disease | lower face morphology measurement | 2.85e-03 | 109 | 158 | 4 | EFO_0010948 | |
| Disease | anemia (implicated_via_orthology) | 2.86e-03 | 15 | 158 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | 2-hydroxyglutarate measurement | 3.25e-03 | 16 | 158 | 2 | EFO_0021506 | |
| Disease | fourth ventricle volume measurement | 3.25e-03 | 16 | 158 | 2 | EFO_0010303 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 3.57e-03 | 364 | 158 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | high altitude adaptation | 3.68e-03 | 17 | 158 | 2 | EFO_0009105 | |
| Disease | sphingomyelin 14:0 measurement | 3.68e-03 | 17 | 158 | 2 | EFO_0010390 | |
| Disease | Malignant neoplasm of skin | 3.93e-03 | 59 | 158 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 3.93e-03 | 59 | 158 | 3 | C0037286 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 4.14e-03 | 121 | 158 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | Cerebrovascular accident | 4.52e-03 | 62 | 158 | 3 | C0038454 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 4.54e-03 | 200 | 158 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | Colorectal Carcinoma | ERCC6 ZNF155 SYNE1 ARFGEF1 CLSTN2 INTS13 SETBP1 ZNF432 KDM6A ZNF292 | 4.68e-03 | 702 | 158 | 10 | C0009402 |
| Disease | body fat percentage | 4.93e-03 | 488 | 158 | 8 | EFO_0007800 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 5.14e-03 | 206 | 158 | 5 | EFO_0004612, EFO_0020947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HKKREHIENDHFKVA | 161 | A8MVM7 | |
| ISHSQIAHLEERNKH | 721 | Q8TC20 | |
| EQKDRQHTLKHFEHV | 501 | P05067 | |
| KHAQHHDRVDNLVLD | 1476 | Q86V15 | |
| HKHLNKHRDFLQEVC | 1466 | Q9UIF9 | |
| EAKQMEKERHRQHHH | 216 | Q9Y6D6 | |
| SDSHEKEEDLLHKNH | 11 | Q96IX9 | |
| QRFTNEDHLAVHKHK | 16 | P17544 | |
| SHRHQKEKDLFHENC | 621 | Q8IYA2 | |
| HKDRIQHALETIHHL | 301 | Q8TDJ6 | |
| HHDKHEDNKQEENKE | 106 | P20930 | |
| HEDQVSDKEHVNHLI | 791 | Q9H4D0 | |
| KEQRHLHNKEHFRAK | 1226 | Q14692 | |
| SAQHLEVHLKQKEQH | 706 | O14578 | |
| KHHSVAEEETLEKHL | 1186 | Q03468 | |
| EEHRDLALQRHKHHM | 276 | Q6NXG1 | |
| LEKVLEKINSHHLHN | 836 | Q5JSJ4 | |
| KHQIRNASNVKHHDS | 506 | Q9Y2R2 | |
| VELLHHKDAHVDFLK | 281 | Q9NVM9 | |
| ALRHKSEIEHHRNKI | 1521 | Q9HCM3 | |
| VSHDEHTHQEIKGRK | 156 | P11182 | |
| EEQFVHHIRVHSAKK | 171 | Q13127 | |
| HLEESQKKREHHLLE | 176 | Q9NWR8 | |
| LKLQQHVDKLEHHST | 741 | Q9NS87 | |
| HHTVQLKREKLHDEE | 651 | Q8N9B5 | |
| HLNSSDIHHINEIKR | 431 | Q09328 | |
| KERDKHLKEHQAHVE | 766 | Q13439 | |
| HLKEHQAHVENLEAD | 771 | Q13439 | |
| MNRHHLQDHFLEIDK | 1 | Q8TDS4 | |
| SHLENHKNVHRAIEE | 636 | Q03001 | |
| ALEDDIINHNKHLHQ | 5546 | Q03001 | |
| ELAKHHVLQNDVLAH | 6416 | Q03001 | |
| EQIHKKLHHTEDQKA | 331 | Q5T655 | |
| KLHHTEDQKAEVEQH | 336 | Q5T655 | |
| HKEEFQKELHLDDHK | 46 | P54707 | |
| SLREENEKRSHHKDH | 1046 | O15550 | |
| NQLVHFLRNHKQEKH | 256 | Q8NHQ9 | |
| HFLHHVTDLKKAQIN | 51 | A8MZ26 | |
| LQHKISETLESRHHK | 1656 | Q3V6T2 | |
| HNLSLHSKFIKVHNE | 156 | P98177 | |
| LKHSLDREEHSLHQL | 196 | Q9Y5G2 | |
| AKHHVLKNDVLAHQA | 2391 | O94854 | |
| REQHIKAHEVAQAKH | 1016 | P50748 | |
| SEDHHSHRRLEKNLE | 931 | Q8IWU2 | |
| HMHENQIIHRDLKAE | 186 | Q8IY84 | |
| HQDTQAHHALLQKLK | 2781 | O95613 | |
| ELLEKEIQEHINAHH | 926 | Q66GS9 | |
| ITDIKRLDHDLKHAH | 341 | Q8IUR7 | |
| KKHLTHCQSRHNEEA | 781 | Q96JM3 | |
| QKHTDKADALHQQHE | 36 | Q8N1L9 | |
| KIHEHLKTSAEQHQR | 1276 | Q8IWJ2 | |
| DKHLTLQQQVHKHES | 436 | Q5T1N1 | |
| QKCLHEDKNLVHVAH | 91 | Q9BPY3 | |
| HHIHRDIKSANILLD | 306 | Q9NWZ3 | |
| LMAQCRDLENHHHEK | 401 | Q9H069 | |
| RDLENHHHEKLLEIS | 406 | Q9H069 | |
| AEFQKQHDHLTRQHE | 96 | Q9UQL6 | |
| QLAALKKHHEEEIVH | 66 | Q9UII2 | |
| EISHRHQKEKDLFHE | 806 | A2RUR9 | |
| KKIEHHARHLQNEDI | 31 | A0A1B0GVR7 | |
| HILSHLHEVRHKDQK | 176 | Q9ULX7 | |
| EKEHEALHKENQRSH | 581 | Q9Y2H2 | |
| IISLRKDLNEDDHHH | 321 | Q9ULF5 | |
| FLRTNHLKKHLNSHE | 711 | Q9UKN5 | |
| KHQEQHHPELEDKDL | 206 | Q16799 | |
| FNRKDHLKNHLQTHD | 71 | Q9UM63 | |
| ENVREALLKRHHHQN | 206 | Q9Y6M7 | |
| HKELVIHILDKQDHQ | 626 | O60522 | |
| HDLTDLHQHETANLK | 341 | Q9ULS5 | |
| DHLQAKLKQNVHAHL | 3996 | Q8NF91 | |
| KHHHVTLEASQKELQ | 2871 | Q8WXH0 | |
| DTNKDHRKAVHHFVN | 236 | Q9H0K6 | |
| VQTLLQDHKHHDKFT | 141 | Q9H1U9 | |
| MNRHHLQDHFLEIDK | 1 | P49019 | |
| TNLDRHLKKHEHENA | 1021 | Q9HAZ2 | |
| HLKKHEHENAPVSQH | 1026 | Q9HAZ2 | |
| HLHLDHNKIKSVNVS | 286 | O60938 | |
| HDHHIVHRDLKTENL | 141 | A0A0B4J2F2 | |
| HDHHIVHRDLKTENL | 141 | P57059 | |
| TIHSQDQEHGHKENK | 331 | Q02383 | |
| HIHELEKVKKQLDHE | 1526 | Q9Y623 | |
| HHKHNLKHRYELQET | 46 | O60285 | |
| KVREALLKKHHHQNE | 211 | Q2Y0W8 | |
| HQAHRHQDHRKEEVE | 316 | P23327 | |
| KHLEQQEKHLEHPEQ | 501 | P07476 | |
| RQFEKHIKEHHLRSQ | 111 | Q2KHM9 | |
| KDHLTRHVKKSHSQE | 231 | Q9UPG8 | |
| EETNKHDTHINIHKA | 371 | O00463 | |
| HDTHINIHKAQLSKN | 376 | O00463 | |
| QELRKHHSAEHKGLQ | 46 | Q6UX46 | |
| THQQLEEAQKEHTHL | 976 | Q9UPV0 | |
| ESHLQIKNHLIKRSH | 771 | Q70EK8 | |
| IKNHLIKRSHVHEDN | 776 | Q70EK8 | |
| IPKDHNAREHIHQSD | 801 | Q70EK8 | |
| HLKNHLHTHDPNKET | 106 | Q6DJT9 | |
| KEKTVQHQVAAHHEA | 2901 | A4UGR9 | |
| KQVDHHSKDTTLIHQ | 181 | A6NCW0 | |
| AAELNHKEEHSLHVQ | 51 | Q9UHF7 | |
| HIHQVHKEKSDEEEQ | 771 | Q9Y4E5 | |
| HQKIHAEVKTQETHE | 586 | O75820 | |
| LHKNHIVHRDLKPDN | 351 | Q8TDR2 | |
| HLAIKDDKKHHDAEH | 176 | Q04724 | |
| NSDLIKHQRTHLDEK | 421 | Q6P1L6 | |
| HEHAKAKRHNLAIDL | 91 | Q9UPT9 | |
| RHDNDLLHHQKIQTL | 116 | P51786 | |
| DLHHANAGTNVKHKR | 806 | P61129 | |
| KQVDHHSKDTTLIHQ | 181 | A6NCW7 | |
| HLKAEHQNNDENAKH | 691 | Q13129 | |
| GLDHNIHIKCKREHQ | 1026 | Q13129 | |
| HLPIKDEKKHHDNDH | 181 | Q04727 | |
| DEKKHHDNDHQRDRD | 186 | Q04727 | |
| LSHHENIVKARKKEH | 256 | Q8NDV3 | |
| ESKKEHRVQHHDKEI | 6 | Q9NX95 | |
| RTHLQDLKEVTHNIH | 306 | Q9UH03 | |
| LHDKDLREIQHHLKK | 146 | Q99962 | |
| TEAHKEIHSQQVKEH | 116 | Q9P2W9 | |
| QSKHQKHQAFEAELH | 1586 | Q13813 | |
| FRNETDLQLHVKHNH | 761 | Q96K83 | |
| KQVDHHSKDTTLIHQ | 181 | D6R9N7 | |
| HSVKDKHNTKERHLS | 91 | Q9HAH1 | |
| SNLLRHIFNKHNDKH | 2271 | O60281 | |
| KQVDHHSKDTTLIHQ | 181 | A8MUK1 | |
| KQVDHHSKDTTLIHQ | 181 | D6R901 | |
| LHEKFEHLKRVHQEE | 366 | Q92599 | |
| KQVDHHSKDTTLIHQ | 181 | D6RCP7 | |
| EVLLDRHQQHKHEID | 406 | P02549 | |
| HRRKEVSEENHNHAN | 1011 | Q9H2K2 | |
| KDDHRHLNQFIAHAA | 31 | P0DI81 | |
| AHLTVKDEKNHHELD | 176 | Q04726 | |
| KDEKNHHELDHRERE | 181 | Q04726 | |
| HKTNLNKHERIHTGE | 291 | P98182 | |
| RNTLSHHEETLQHEK | 196 | Q06730 | |
| EHEHKLKVVRDQISH | 341 | Q9C026 | |
| HLSSEAEEHHREKLQ | 126 | Q8N9V2 | |
| SKETLEHLHAHQEQT | 641 | O43167 | |
| KQVDHHSKDTTLIHQ | 181 | C9JPN9 | |
| LSHHNDKLEVHRKEN | 216 | Q9UJU3 | |
| LNTIKEHLEEEIKHH | 901 | Q15643 | |
| KQVDHHSKDTTLIHQ | 181 | Q0WX57 | |
| LHNHLESHKLTSKAE | 471 | P17010 | |
| QVSKHQRTHEIEKNH | 191 | O94892 | |
| HDQRHAGNKHIKDQL | 126 | P17035 | |
| HDSQLKEHKRIHTGE | 271 | Q12901 | |
| KQLDHHSKDTTLIHQ | 181 | P0C7H9 | |
| KQVDHHSKDTTLIHQ | 181 | P0C7I0 | |
| IKQHIAKTHNEDHEE | 21 | Q01118 | |
| EITAHRKKHEEAIHA | 716 | Q9NRL3 | |
| AHLNQHRKIHTREKL | 411 | Q8N859 | |
| TSLDVHHQKQHLGEK | 51 | Q13106 | |
| QKQLLRHAKHHTDQR | 356 | Q96JP5 | |
| LKNHQKSFHAIDHRL | 531 | Q8NAP3 | |
| KQVDHHSKDTTLIHQ | 181 | Q6QN14 | |
| AFLQKAHLTEHQKIH | 411 | O75123 | |
| KQVDHHSKDTTLIHQ | 181 | D6RA61 | |
| KVSFHNHLESHKLIN | 426 | Q9Y462 | |
| KDDHRHLNQFIAHAA | 31 | P0DI82 | |
| DQHDHRHAGNKPIKD | 71 | Q6ZNG1 | |
| HKHKEDRILGTHDNL | 1156 | Q9Y6X0 | |
| HQEQGHQLLKKHLDT | 41 | P51580 | |
| KQVDHHSKDTTLIHQ | 181 | C9J2P7 | |
| KQVDHHSKDTTLIHQ | 181 | D6RBQ6 | |
| NSSLVSHQEIHHKEK | 426 | O43309 | |
| SHHHDDNIVHKRDKV | 221 | Q14590 | |
| VVDHLKQHLLTDHTN | 1826 | Q9H2Y7 | |
| DHKLHIDHEIETLQN | 626 | Q8IWU5 | |
| KQVDHHSKDTTLIHQ | 181 | Q6R6M4 | |
| LHKIQQDVAEHHKQI | 61 | Q9H808 | |
| KQVDHHSKDTTLIHQ | 181 | D6RJB6 | |
| SLSNHQRVHTEKKHE | 256 | B7Z6K7 | |
| HNLDLHIHNKSNAAK | 201 | P51508 | |
| HEHKDNIQDAVTIHE | 401 | Q7Z3T8 | |
| TLQDHRKHIHEVHSK | 961 | Q9NUA8 | |
| HSALLQHQRNHSEEK | 776 | Q8WXB4 | |
| EEALSQHLESALHKH | 3541 | Q15911 | |
| KQVDHHSKDTTLIHQ | 181 | C9JVI0 | |
| IDELHKHANEKEDIH | 451 | Q9C099 |